Orient Office
FDA import alert and refusal historyDamascus, SyriaFEI 3008062719
As of October 25, 2026, Orient Office (Damascus, Syria) is on the red list of FDA Import Alert 99-19 (Food products: Salmonella) for summac spice (sumac), published by FDA on June 8, 2010, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-19 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Orient Office
1 record, newest first. Each line links to the FDA page it came from.
2010
- Import alert listingListed on Import Alert 99-19red listSummac Spice (Sumac)Source
Questions about Orient Office
- Is Orient Office on an FDA import alert?
- Yes. As of October 25, 2026, Orient Office is on the red list of FDA Import Alert 99-19, “Food products: Salmonella”, for summac spice (sumac); FDA published the listing on June 8, 2010.
- Has FDA refused shipments from Orient Office?
- No FDA import refusals for Orient Office appear in FDA's refusal data since October 2016, as of October 25, 2026.
- What is Orient Office's FEI number?
- Orient Office's FDA Establishment Identifier (FEI) is 3008062719.
- Can shipments from Orient Office still enter the U.S.?
- Shipments of summac spice (sumac) from Orient Office can be detained without physical examination under Import Alert 99-19; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Orient Office?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.